Log In
Join
14th May 2024
06:00
Hutchmed China Ltd - HUTCHMED Initiates Registrational Phase III Trial
14th May 2024
06:00
Hutchmed China Ltd - HUTCHMED Initiates Phase II/III Trial with Hengrui
10th May 2024
12:00
Hutchmed China Ltd - Result of AGM
8th May 2024
08:30
Hutchmed China Ltd - Directorate Change
26th April 2024
12:30
Hutchmed China Ltd - Positive CHMP Opinion for Fruquintinib
22nd April 2024
08:30
Hutchmed China Ltd - Vesting of Awards Under the LTIP
8th April 2024
08:30
Hutchmed China Ltd - 2023 Annual Report and Notice of AGM
5th April 2024
08:30
Hutchmed China Ltd - Data to be Presented at AACR Congress 2024
2nd April 2024
06:00
Hutchmed China Ltd - HUTCHMED and Innovent Announce NDA Acceptance
28th March 2024
07:00
Hutchmed China Ltd - Savolitinib sNDA Accepted in China
22nd March 2024
07:00
Hutchmed China Ltd - Initiation of Registration Stage of P2/3 Trial
14th March 2024
09:00
Hutchmed China Ltd - LTIP and Share Option Scheme
5th March 2024
08:30
Hutchmed China Ltd - Vesting of awards under the LTIP
28th February 2024
12:45
Hutchmed China Ltd - Publication of Form 20-F
28th February 2024
11:30
Hutchmed China Ltd - 2023 Full Year Results and Business Updates
7th February 2024
07:00
Hutchmed China Ltd - Presentation of Phase III Data on Fruquintinib
Load more
HUTCHMED (China) Limited (HCM.L)
Share Price & News
Follow
Unfollow
Price Snapshot
Last Trades
Bid
-
-
-
Ask
High
-
OPEN
-
VOL
-
MKT CAP
-M
LOW
-
CLOSE
-
SHARES IN ISSUE
871.04M
Profile
Financials
RNS
Chart
Media
Board & Advisors
More...
HUTCHMED (China) Limited Financials
Watchlist